TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

NewLink Pancreatic Cancer Vaccine Fails, May Even Harm Patients
STOCKS

Hollis-Eden Namesake Fired 'For Cause'

  • By Adam Feuerstein
  • Mar 24, 2009 1:30 AM EDT
Dating Sites: Best, Worst & Weirdest
INVESTING

Health Winners & Losers: Johnson & Johnson

  • By Elizabeth Trotta
  • Oct 1, 2008 4:15 PM EDT
ESMO Preview: Cancer Stocks to Watch
STOCKS

Advanced Life, Wyeth Ink Marketing Deal

  • By Adam Feuerstein
  • Oct 1, 2008 10:12 AM EDT
Germany Slaps PTC Therapeutics With Big Drug Price Cut
STOCKS

Biotech Defense Plays: Biogen, Genentech, Gilead, Onyx

  • By Adam Feuerstein
  • Jan 24, 2008 8:37 AM EST
INVESTING

Friday's Small-Cap Winners & Losers

  • By Mike Taylor
  • Jan 18, 2008 3:59 PM EST
Dating Sites: Best, Worst & Weirdest
INVESTING

Tuesday's Health Winners & Losers

  • By Elizabeth Trotta
  • Dec 11, 2007 2:54 PM EST
PTC Therapeutics Duchenne Drug Stuck on Conditional Approval Status in Europe
STOCKS

Biotech Notebook: Medarex, Panacos, Advanced Life

  • By Adam Feuerstein
  • Dec 11, 2007 1:46 PM EST
Dating Sites: Best, Worst & Weirdest
INSURANCE

Biotech Stocks Face Make-or-Break FDA Rulings

  • By Adam Feuerstein
  • Dec 5, 2007 6:04 AM EST
STOCKS

Feuerstein's Biotech-Stock Mailbag

  • By Adam Feuerstein
  • Dec 1, 2007 12:16 PM EST
Dating Sites: Best, Worst & Weirdest
INVESTING

Thursday's Health Winners & Losers

  • By Elizabeth Trotta
  • Nov 15, 2007 3:18 PM EST
Karyopharm Sees Quicker U.S. Approval Path for Multiple Myeloma Drug
STOCKS

Biotech Update: Exelixis, Oculus, Medarex, Flamel

  • By Adam Feuerstein
  • Nov 1, 2007 5:49 AM EDT
Chiasma Craters on FDA Drug Rejection
STOCKS

Biotech's Hot Season: Get Ready

  • By Adam Feuerstein
  • Aug 31, 2007 5:59 AM EDT
Dating Sites: Best, Worst & Weirdest
INVESTING

Tuesday's Small-Cap Winners & Losers

  • By Sarina Penn
  • Aug 28, 2007 4:19 PM EDT
Dating Sites: Best, Worst & Weirdest
INVESTING

Stockpickr Lists: Option Care Soars on Buyout

  • By Stockpickr Staff
  • Jul 3, 2007 10:52 AM EDT
Dating Sites: Best, Worst & Weirdest
INVESTING

Monday's Small-Cap Winners & Losers

  • By Sarina Penn
  • Jul 2, 2007 3:59 PM EDT
Dating Sites: Best, Worst & Weirdest
INVESTING

Thursday's Health Winners & Losers

  • By Elizabeth Trotta
  • Jun 21, 2007 4:37 PM EDT
STOCKS

New Antibiotic Awaits Fate

  • By Robert Steyer
  • Nov 30, 2006 11:42 AM EST
Dating Sites: Best, Worst & Weirdest
INVESTING

Thursday's Health Winners & Losers

  • By Althea Chang
  • Sep 7, 2006 2:56 PM EDT
Dating Sites: Best, Worst & Weirdest
STOCKS

Medical IPOs Hunt for Cure

  • By Robert Steyer
  • Jan 5, 2006 3:15 PM EST
Dating Sites: Best, Worst & Weirdest
STOCKS

Health Stocks in Motion: Possis

  • By TSC Staff
  • Aug 8, 2005 1:09 PM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.